迪恩生物 (832711.OC)

+ 收藏

现金流量表(迪恩生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 9,476,988.8518,561,506.306,587,428.9224,666,047.9311,043,600.69
 收到其他与经营活动有关的现金(元) 2,330,280.90992,728.50391,735.852,113,759.17920,005.36
 经营活动现金流入小计(元) 11,807,269.7519,554,234.806,979,164.7726,779,807.1011,963,606.05
 购买商品、接受劳务支付的现金(元) 2,764,282.8010,496,541.782,503,744.934,614,009.433,344,113.68
 支付给职工以及为职工支付的现金(元) 5,680,939.1011,542,639.675,823,271.9112,002,146.556,494,405.37
 支付的各项税费(元) 538,206.951,317,992.68773,097.75774,118.29164,827.79
 支付其他与经营活动有关的现金(元) 2,112,229.734,179,439.633,302,477.728,999,723.023,351,188.77
 经营活动现金流出小计(元) 11,095,658.5827,536,613.7612,402,592.3126,389,997.2913,354,535.61
 经营活动产生的现金流量净额(元) 711,611.17-7,982,378.96-5,423,427.54389,809.81-1,390,929.56
二、投资活动产生的现金流量
 收回投资收到的现金(元) --1,600,000.001,847,409.77-
 取得投资收益收到的现金(元) -138,099.00138,099.00--
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 32,257.17421,312.14276,317.03113,940.00-
 收到其他与投资活动有关的现金(元) -1,600,000.00---
 投资活动现金流入小计(元) 32,257.172,159,411.142,014,416.031,961,349.77-
 购建固定资产、无形资产和其他长期资产支付的现金(元) 4,261,037.96957,825.69885,422.03891,188.241,660,110.06
 投资活动现金流出小计(元) 4,261,037.96957,825.69885,422.03891,188.241,660,110.06
 投资活动产生的现金流量净额(元) -4,228,780.791,201,585.451,128,994.001,070,161.53-1,660,110.06
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 12,100,000.008,250,000.002,150,000.003,100,000.002,100,000.00
 筹资活动现金流入小计(元) 12,100,000.008,250,000.002,150,000.003,100,000.002,100,000.00
 偿还债务支付的现金(元) 10,100,000.006,150,000.003,000,000.003,100,000.003,003,529.17
 分配股利、利润或偿付利息支付的现金(元) 99,815.97101,748.1039,985.5793,710.3549,672.22
 支付其他与筹资活动有关的现金(元) 378,540.991,131,862.511,131,862.512,690,392.391,558,531.09
 筹资活动现金流出小计(元) 10,578,356.967,383,610.614,171,848.085,884,102.744,611,732.48
 筹资活动产生的现金流量净额(元) 1,521,643.04866,389.39-2,021,848.08-2,784,102.74-2,511,732.48
五、现金及现金等价物净增加额(元) -1,995,526.58-5,914,404.12-6,316,281.62-1,324,131.40-5,562,772.10
 加:期初现金及现金等价物余额(元) 7,869,853.8613,784,257.9813,784,257.9815,108,389.3815,108,389.38
 期末现金及现金等价物余额(元) 5,874,327.287,869,853.867,467,976.3613,784,257.989,545,617.28
补充资料:
 净利润(元) -847,680.38-15,220,351.40-1,954,466.91-8,134,567.96-2,490,429.49
 资产减值准备(元) -7,724,640.95144,821.311,928,731.6330,221.71
 固定资产和投资性房地产折旧(元) 875,413.751,988,795.111,006,383.042,141,629.911,111,118.42
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 875,413.751,988,795.111,006,383.042,141,629.911,111,118.42
 无形资产摊销(元) 95,460.56225,586.08112,793.10185,586.2082,793.10
 长期待摊费用摊销(元) 283,348.23675,722.28392,450.97965,255.63632,627.83
 处置固定资产、无形资产和其他长期资产的损失(元) -6,939.85-1,955,886.32-136,689.04-298,727.75-
 公允价值变动损失(元) ----261,050.29-
 财务费用(元) 214,056.63620,368.26307,348.33915,320.22485,454.78
 投资损失(元) --138,099.00-138,081.60-1,374,621.7811,979.26
 递延所得税(元) -43,287.7148,551.07-231,759.64-1,329,232.49-89,723.20
  其中:递延所得税资产减少(元) -43,287.7148,551.07-231,759.64-1,329,232.49-89,723.20
 存货的减少(元) 762,262.771,139,866.97297,173.80983,529.9045,734.41
 经营性应收项目的减少(元) -422,598.48-8,022,542.79-8,148,589.952,656,756.26-1,945,462.03
 经营性应付项目的增加(元) -1,377,465.262,909,542.701,888,870.27-841,796.90-721,976.43
 现金的期末余额(元) 5,874,327.287,869,853.867,467,976.3613,784,257.989,545,617.28
 减:现金的期初余额(元) 7,869,853.8613,784,257.9813,784,257.9815,108,389.3815,108,389.38
 现金及现金等价物的净增加额(元) -1,995,526.58-5,914,404.12-6,316,281.62-1,324,131.40-5,562,772.10
公告日期 2024-08-162024-04-032023-08-182023-04-252022-08-18
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院